Abstract: A voltage controlled oscillator circuit comprises a VCO resonator circuit having a first plurality of varactors for varying a frequency of the VCO resonator circuit, the VCO resonator circuit being symmetrical with respect to VCO circuit ground and providing a signal having a frequency, the frequency depending on a tuning voltage applied to the first plurality of varactors, and a second plurality of varactors for compensating a drift of the frequency depending on a compensation voltage, a temperature sensor circuit sensing an ambient temperature of the VCO resonator circuit and providing a temperature dependent signal, and a temperature compensation circuit providing the compensation voltage depending on the temperature dependent signal. Furthermore, a phase locked loop (PLL) circuit, an automotive radar device and a method for compensating a frequency drift of a VCO resonator circuit are presented.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Abstract: A PCB assembly, includes a shield-can and a PCB, the shield-can forms resisting portions and hook members; The PCB has a top surface and an opposite bottom surface, and the PCB defines engaging holes through the top surface and bottom surface; The shield-can be detachably assembled on the PCB, the resisting portions resist against the top surface of the PCB, and the hook members pass through the engaging holes, the distal ends of the hook members resist against the bottom surface of the PCB.

Abstract: The present invention provides a Relay Node Placement Method in Wireless Body Sensor Network. It provides a sensor data collection location and a plurality of sensor locations. Then based on those sensor locations and their corresponding time delays, a sensor location data group is generated, then based on the sensor location data group, a set cover problem is set up. Through an approximation algorithm, within linear time, the solution of that set cover problem is then solved so as to decide the minimal quantity of the first relay nodes of the trunk of human body; moreover, based on a given human body model, a plurality of second relay node candidate locations, those first relay node and the sensor data collection location, a minimal spanning tree problem is set up so as to decide a plurality of second relay node locations.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.

Abstract: The invention relates to genes for promoting rapid growth of plant, characterized in genes that are Banana ABC transporter MhPDR1 or MhPDR2 genes, wherein the transporters have amino acid sequences depicted in SEQ ID No: 1 and SEQ ID No: 3, respectively, and the genes have nucleotide sequences depicted in SEQ ID No: 2 and SEQ ID No: 4, respectively. The invention provides further applications of the banana transporter MhPDR1 or MhPDR2 genes, characterized in that the over-expression of the genes in a plant can promote rapid growth of the plant. In addition, the present invention provides a transgenic plant or partial organ, tissue or cells thereof containing the genes or derivatives thereof; as well as provides further a method for promoting rapid growth of a plant.

Abstract: The present invention relates to processes for preparing enantiomerically pure cyclopropyl amine derivatives and salts thereof; the chiral intermediates such as the chiral salts are useful for the preparation of such chiral compounds and salts; pharmaceutical compositions comprising the compounds and salts; and method of using such compositions. The chiral cyclopropyl amine derivatives are useful for binding to histamine H3 receptor sites and for providing therapeutic agents for histamine H3 mediated disease.

Abstract: A PCB assembly, includes a shield-can and a PCB, the shield-can forms resisting portions and hook members; The PCB has a top surface and an opposite bottom surface, and the PCB defines engaging holes through the top surface and bottom surface; The shield-can be detachably assembled on the PCB, the resisting portions resist against the top surface of the PCB, and the hook members pass through the engaging holes, the distal ends of the hook members resist against the bottom surface of the PCB.

Abstract: A latching structure of electronic device includes a lower housing, a circuit board and an upper housing. The lower housing forms at least one fixing pole; The circuit board defines at least one positioning slot corresponding to the fixing pole; The upper housing defines at least one engaging hole corresponding to the fixing pole. The fixing pole, passes through the positioning slot and the engaging hole, and the distal end of the fixing pole becomes liquefied, secures the lower housing with the circuit board and the upper housing, the circuit board is clamped between the lower housing and the upper housing.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.

Abstract: A flower tissue-specific promoter, and uses thereof, is the promoter for Phalaenopsis 1-aminocyclopropane-1-carboxylic acid synthase, ACC synthase gene PtACS2, and has a sequence as shown in SEQ ID No: 2. The invention further provides a gene expression cassette, which is composed of a promoter having a DNA sequence as SEQ ID No: 2, and a polynucleotide with an open reading frame linked to the 3? end of said promoter, wherein said promoter can activate transcription of said polynucleotide in an organism containing said gene expression cassette. The invention provides furthermore a gene expression vector, which is composed of a promoter having a DNA sequence as SEQ ID No: 2. The invention provides further a method for producing a transgenic plant or parts of organ, tissue or cell of the transgenic plant that contain a gene expression cassette described above.

Abstract: The present disclosure relates to a wide angle lens system. The wide angle lens system includes, in order from the object side to the image side thereof, a first lens of positive refraction power, a second lens of positive refraction power, and a third lens of negative refraction power. The wide angle lens system satisfies the following condition: 0.45<f/TTL<0.75; and 1.4<f1/f<2.4. Wherein, TTL is a distance from a surface of the first lens facing the object side of the wide angle lens system to an image plane, f is a focal length of the wide angle lens system, and f1 is a focal length of the first lens.

Abstract: The invention provides a promoter that has high expression strength and can be over-expressed in various tissues of plant, said promoter is a promoter for banana polyubiquitin (polyubiquitin) gene MhUBQ1, and has a sequence as SEQ ID No: 3. The invention provides further a gene expression cassette that contains a promoter comprising a DNA sequence as SEQ ID No: 3, and a polynucleotide having a open reading frame (ORF) linked to the 3? terminal of said promoter, wherein said promoter can activate the transcription of said polynucleotide in a organism containing said gene expression cassette. The invention provides further a gene expression vector that contains a promoter having a DNA sequence as SEQ ID No: 3. Also, the invention provides a process for producing a transgenic plant or part of organ, tissue or cell thereof containing the above-described gene expression cassette.

Abstract: A process for the preparation of compounds of formula (I) or a salt thereof wherein X1, X2, X3, X4, Rx, u, R2, R1g, z, and A1 are as defined in the specification is disclosed.

Abstract: A voltage controlled oscillator circuit comprises a VCO resonator circuit having a first plurality of varactors for varying a frequency of the VCO resonator circuit the VCO resonator circuit being symmetrical with respect to VCO circuit ground and providing a signal having a frequency, the frequency depending on a tuning voltage applied to the first plurality of varactors, and a second plurality of varactors for compensating a drift of the frequency depending on a compensation voltage, a temperature sensor circuit sensing an ambient temperature of the VCO resonator circuit and providing a temperature dependent signal, and a temperature compensation circuit providing the compensation voltage depending on the temperature dependent signal. Furthermore, a phase locked loop (PLL) circuit, an automotive radar device and a method for compensating a frequency drift of a VCO resonator circuit are presented.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Abstract: The invention relates to genes for promoting rapid growth of plant, characterized in genes that are Banana ABC transporter MhPDR1 or MhPDR2 genes, wherein the transporters have amino acid sequences depicted in SEQ ID No: 1 and SEQ ID No: 3, respectively, and the genes have nucleotide sequences depicted in SEQ ID No: 2 and SEQ ID No: 4, respectively. The invention provides further applications of the banana transporter MhPDR1 or MhPDR2 genes, characterized in that the over-expression of the genes in a plant can promote rapid growth of the plant. In addition, the present invention provides a transgenic plant or partial organ, tissue or cells thereof containing the genes or derivatives thereof; as well as provides further a method for promoting rapid growth of a plant.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Abstract: The present invention relates to the use of compounds of formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.

Abstract: A temperature compensation circuit, comprises a temperature sensor circuit. The circuit comprises two or more temperature sensitive devices. In use, the devices are operated at different current densities and sense virtually the same ambient temperature. The devices provide temperature dependent signals having linear components with slopes of identical signs. The circuit further comprises one of more differential signal providing device for generating a difference of the signals generated by the temperature sensitive devices. A method for generating a voltage reference with a well-defined temperature behaviour, comprises applying different current densities to two or more temperature sensitive devices of a temperature sensor circuit; sensing virtually the same ambient temperature with the two or more temperature sensitive devices.